Abstract:BACKGROUND:Randomized controlled trials are considered the gold standard for evaluating experimental treatments but often require large sample sizes. Single-arm trials require smaller sample sizes but are subject to bias when using historical control data for comparative inferences. This article presents a Bayesian adaptive synthetic-control design that exploits historical control data to create a hybrid of a single-arm trial and a randomized controlled trial.METHODS:The Bayesian adaptive synthetic control design has two stages. In stage 1, a prespecified number of patients are enrolled in a single arm given the experimental treatment. Based on the stage 1 data, applying propensity score matching and Bayesian posterior prediction methods, the usefulness of the historical control data for identifying a pseudo sample of matched synthetic-control patients for making comparative inferences is evaluated. If a sufficient number of synthetic controls can be identified, the single-arm trial is continued. If not, the trial is switched to a randomized controlled trial. The performance of The Bayesian adaptive synthetic control design is evaluated by computer simulation.RESULTS:The Bayesian adaptive synthetic control design achieves power and unbiasedness similar to a randomized controlled trial but on average requires a much smaller sample size, provided that the historical control data patients are sufficiently comparable to the trial patients so that a good number of matched controls can be identified in the historical control data. Compared to a single-arm trial, The Bayesian adaptive synthetic control design yields much higher power and much smaller bias.CONCLUSION:The Bayesian adaptive synthetic-control design provides a useful tool for exploiting historical control data to improve the efficiency of single-arm phase II clinical trials, while addressing the problem of bias when comparing trial results to historical control data. The proposed design achieves power similar to a randomized controlled trial but may require a substantially smaller sample size.

Bayesian Sequentially Monitored Multi-arm Experiments with Multiple Comparison Adjustments

A Bayesian Group Sequential Design for Randomized Biosimilar Clinical Trials with Adaptive Information Borrowing from Historical Data

Experimentation Platforms Meet Reinforcement Learning: Bayesian Sequential Decision-Making for Continuous Monitoring

A Bayesian Response-Adaptive Covariate-Balanced Randomization Design with Application to A Leukemia Clinical Trial

BASIC: A Bayesian Adaptive Synthetic-Control Design for Phase II Clinical Trials.

More Powerful Multiple Testing in Randomized Experiments with Non-Compliance

Precise unbiased estimation in randomized experiments using auxiliary observational data

Empirical Bayes Multistage Testing for Large-Scale Experiments

Rapid and Scalable Bayesian AB Testing

A Bayesian Bradley-Terry model to compare multiple ML algorithms on multiple data sets

Practical Batch Bayesian Sampling Algorithms for Online Adaptive Traffic Experimentation

Bayesian Causal Inference in Sequentially Randomized Experiments with Noncompliance

Bayesian model selection on linear mixed-effects models for comparisons between multiple treatments and a control

Sequential monitoring of response-adaptive randomized clinical trials

Short-lived High-volume Multi-A(rmed)/B(andits) Testing

Empirical Bayes for Large-scale Randomized Experiments: a Spectral Approach

A framework for testing non-inferiority in a three-arm, sequential, multiple assignment randomized trial

Estimation in Parallel Randomized Experiments

Rematching on-the-fly: sequential matched randomization and a case for covariate-adjusted randomization

A Bayesian platform trial design with hybrid control based on multisource exchangeability modelling

A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials